In this study, we found that FBXW7 inactivation promoted the senescence of p53 wild-type cancer and normal cells and that p53 induction played a causal role in FBXW7 deficiency-induced cellular senescence both in vitro and in vivo. This evidence concerns the gene TP53 and cancer.